BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 22003387)

  • 21. Herpes simplex virus type 1 and Alzheimer's disease: increasing evidence for a major role of the virus.
    Itzhaki RF
    Front Aging Neurosci; 2014; 6():202. PubMed ID: 25157230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Herpes simplex virus type 1 in brain and risk of Alzheimer's disease.
    Itzhaki RF; Lin WR; Shang D; Wilcock GK; Faragher B; Jamieson GA
    Lancet; 1997 Jan; 349(9047):241-4. PubMed ID: 9014911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Herpes simplex infection and the risk of Alzheimer's disease: A nested case-control study.
    Lövheim H; Gilthorpe J; Johansson A; Eriksson S; Hallmans G; Elgh F
    Alzheimers Dement; 2015 Jun; 11(6):587-92. PubMed ID: 25304990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Herpes Simplex Virus Type 1 and Other Pathogens are Key Causative Factors in Sporadic Alzheimer's Disease.
    Harris SA; Harris EA
    J Alzheimers Dis; 2015; 48(2):319-53. PubMed ID: 26401998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microbes and Alzheimer's Disease.
    Itzhaki RF; Lathe R; Balin BJ; Ball MJ; Bearer EL; Braak H; Bullido MJ; Carter C; Clerici M; Cosby SL; Del Tredici K; Field H; Fulop T; Grassi C; Griffin WS; Haas J; Hudson AP; Kamer AR; Kell DB; Licastro F; Letenneur L; Lövheim H; Mancuso R; Miklossy J; Otth C; Palamara AT; Perry G; Preston C; Pretorius E; Strandberg T; Tabet N; Taylor-Robinson SD; Whittum-Hudson JA
    J Alzheimers Dis; 2016; 51(4):979-84. PubMed ID: 26967229
    [No Abstract]   [Full Text] [Related]  

  • 26. Herpes and Alzheimer's Disease: Subversion in the Central Nervous System and How It Might Be Halted.
    Itzhaki RF
    J Alzheimers Dis; 2016 Oct; 54(4):1273-1281. PubMed ID: 27497484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alzheimer's Disease-Associated β-Amyloid Is Rapidly Seeded by Herpesviridae to Protect against Brain Infection.
    Eimer WA; Vijaya Kumar DK; Navalpur Shanmugam NK; Rodriguez AS; Mitchell T; Washicosky KJ; György B; Breakefield XO; Tanzi RE; Moir RD
    Neuron; 2018 Jul; 99(1):56-63.e3. PubMed ID: 30001512
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Viral Hypothesis and Antiviral Treatment in Alzheimer's Disease.
    Devanand DP
    Curr Neurol Neurosci Rep; 2018 Jul; 18(9):55. PubMed ID: 30008124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Herpes Viruses and Senile Dementia: First Population Evidence for a Causal Link.
    Itzhaki RF; Lathe R
    J Alzheimers Dis; 2018; 64(2):363-366. PubMed ID: 29889070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Herpes simplex virus type 1 and Alzheimer's disease: possible mechanisms and signposts.
    Itzhaki RF
    FASEB J; 2017 Aug; 31(8):3216-3226. PubMed ID: 28765170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corroboration of a Major Role for Herpes Simplex Virus Type 1 in Alzheimer's Disease.
    Itzhaki RF
    Front Aging Neurosci; 2018; 10():324. PubMed ID: 30405395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of Microbes in the Development of Alzheimer's Disease: State of the Art - An International Symposium Presented at the 2017 IAGG Congress in San Francisco.
    Fülöp T; Itzhaki RF; Balin BJ; Miklossy J; Barron AE
    Front Genet; 2018; 9():362. PubMed ID: 30250480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The helicase-primase inhibitor BAY 57-1293 reduces the Alzheimer's disease-related molecules induced by herpes simplex virus type 1.
    Wozniak MA; Frost AL; Itzhaki RF
    Antiviral Res; 2013 Sep; 99(3):401-4. PubMed ID: 23867133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiscale Analysis of Independent Alzheimer's Cohorts Finds Disruption of Molecular, Genetic, and Clinical Networks by Human Herpesvirus.
    Readhead B; Haure-Mirande JV; Funk CC; Richards MA; Shannon P; Haroutunian V; Sano M; Liang WS; Beckmann ND; Price ND; Reiman EM; Schadt EE; Ehrlich ME; Gandy S; Dudley JT
    Neuron; 2018 Jul; 99(1):64-82.e7. PubMed ID: 29937276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective Effect of Amyloid-β Peptides Against Herpes Simplex Virus-1 Infection in a Neuronal Cell Culture Model.
    Bourgade K; Le Page A; Bocti C; Witkowski JM; Dupuis G; Frost EH; Fülöp T
    J Alzheimers Dis; 2016; 50(4):1227-41. PubMed ID: 26836158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. β-Amyloid peptides display protective activity against the human Alzheimer's disease-associated herpes simplex virus-1.
    Bourgade K; Garneau H; Giroux G; Le Page AY; Bocti C; Dupuis G; Frost EH; Fülöp T
    Biogerontology; 2015 Feb; 16(1):85-98. PubMed ID: 25376108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reactivated herpes simplex infection increases the risk of Alzheimer's disease.
    Lövheim H; Gilthorpe J; Adolfsson R; Nilsson LG; Elgh F
    Alzheimers Dement; 2015 Jun; 11(6):593-9. PubMed ID: 25043910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HSV-1 and Alzheimer's disease: more than a hypothesis.
    Piacentini R; De Chiara G; Li Puma DD; Ripoli C; Marcocci ME; Garaci E; Palamara AT; Grassi C
    Front Pharmacol; 2014; 5():97. PubMed ID: 24847267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous immunoglobulin reduces β amyloid and abnormal tau formation caused by herpes simplex virus type 1.
    Wozniak MA; Itzhaki RF
    J Neuroimmunol; 2013 Apr; 257(1-2):7-12. PubMed ID: 23385080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracerebral propagation of Alzheimer's disease: strengthening evidence of a herpes simplex virus etiology.
    Ball MJ; Lukiw WJ; Kammerman EM; Hill JM
    Alzheimers Dement; 2013 Mar; 9(2):169-75. PubMed ID: 23159044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.